Skip to main content
. 2018 Feb 21;29:38–46. doi: 10.1016/j.ebiom.2018.02.013

Table 1.

Patient data.

Control
Case no. Age at surgery (yr) Duration of seizures (yr) MRI findings in hippocampus Pathological diagnosis Neuronal loss
Watson grade
CA4 CA1 DG
E-1 15 10 TS (T) 0
E-2 2 1 FCD type II (T) 0
E-3 21 2 Ependymoma (T) 0
E-4 20 7 Ganglioglioma (T) 0
E-5 26 3 No significant alterations 0



No-HS
N-1 51 13 No HS 0
N-2 12 6 No HS 1
N-3 25 16 No HS 1
N-4 33 12 No HS, Polymicrogyria (T) –, dis 0
N-5 19 2 No HS 1
N-6 46 19 No HS 1



HS
S-1 32 19 Atrophy HS +++ +++ +, dis 4
S-2 17 8 Atrophy HS, FCD type I (T) +++ +++ +, dis 4
S-3 27 3 Atrophy HS +++ +++ +, dis 4
S-4 37 22 Atrophy HS +++ +++ ++, dis 4
S-5 32 5 Atrophy HS, FCD type I (T) +++ +++ –, dis 4
S-6 53 43 Atrophy HS +++ +++ ++, dis 4
S-7 64 44 Atrophy HS +++ +++ –, dis 4
S-8 42 2 Atrophy HS, FCD type I (T) +++ +++ +, dis 4
S-9 39 23 Atrophy HS, FCD type I (T) +++ +++ +, dis 4
S-10 36 33 Atrophy HS, FCD type I (T) +++ +++ +, dis 4
S-11 23 6 Atrophy HS, FCD type I (T) +++ +++ +, dis 4
S-12 36 7 Atrophy HS, FCD type I (T) +++ +++ –, dis 4
S-13 14 4 Atrophy HS ++ +++ –, dis 3
S-14 27 16 Atrophy HS, FCD type I (T) +++ +++ +, dis 4
S-15 43 34 Atrophy HS +++ +++ +, dis 4
S-16 10 6 Atrophy HS, FCD type I (T) +++ +++ +, dis 4
S-17 32 15 Atrophy HS, FCD type I (T) ++ +++ +, dis 3
S-18 30 28 Atrophy HS +++ +++ –, dis 4
S-19 52 17 Atrophy HS +++ +++ +, dis 4
S-20 44 36 Atrophy HS, FCD type I (T) ++ +++ –, dis 3

HS: Hippocampal sclerosis, EFS: End folium sclerosis, (T): Temporal cortex, TS: Tuberous Sclerosis, FCD: Focal cortical dysplasia, dis: granule cell dispersion. +: mild, ++: moderate, +++: severe neuronal loss.